Assuming patients is required, the following results were found.

  • Common treatment for multiple sclerosis may prolong life

    Institute have found that a widely prescribed drug for multiple sclerosis (MS) is associated with longer survival for patients. The study, published today in the journal Brain, found that people with MS who took a beta interferon drug had a 32 per cent...

    https://mschristian.org/index.php/blog/common-treatment-for-multiple-sclerosis-may-prolong-life
  • Disability progression in multiple sclerosis linked to income, education

    Neighbourhood income and education level is associated with risk of disability progression in patients with multiple sclerosis, suggests new research from the University of British Columbia. UBC researchers, along with colleagues in Wales, compared...

    https://mschristian.org/index.php/blog/disability-progression-in-multiple-sclerosis-linked-to-income-education
  • Forgotten immune cells protective in mouse model of multiple sclerosis

    is also a Howard Hughes Medical Institute investigator. "If we could mobilize those cells to function more effectively in patients with autoimmunity, then we'd have a novel treatment for diseases like multiple sclerosis." A seldom-studied class of...

    https://mschristian.org/index.php/blog/forgotten-immune-cells-protective-in-mouse-model-of-multiple-sclerosis
  • Study shows promise in repairing damaged myelin

    before the compound advances to the stage of a clinical trial involving people. Yet the study provides fresh hope for patients in Oregon and beyond. "It could have a significant impact on patients debilitated by MS," Bourdette said. The discovery, if...

    https://mschristian.org/index.php/blog/study-shows-promise-in-repairing-damaged-myelin
  • Could medical marijuana help older people with their ailments?

    adjustment in dosage, only 21 percent reported side effects. The mostcommon side effects were sleepiness in 13 percent of patients, balance problems in 7 percent and gastrointestinal disturbances in 7 percent. Three percent of the participants stopped...

    https://mschristian.org/index.php/blog/could-medical-marijuana-help-older-people-with-their-ailments
  • Pediatric onset multiple sclerosis study examines baffling, often-overlooked disease

    coatings of nerve cells in the spinal cord and brain, often causing neurological problems. But just 3-10 percent of those patients have pediatric onset MS, which occurs in youths younger than 18. According to Duffy, a nurse practitioner certified in MS...

    https://mschristian.org/index.php/blog/pediatric-onset-multiple-sclerosis-study-examines-baffling-often-overlooked-disease
  • Researchers optimize aptamer with enhanced myelin-binding properties for MS treatment

    central nervous system, in which the immune cells attack myelin sheaths. Regeneration of myelin sheaths is necessary for patients to... read more Dec. 1, 2016 — Multiple sclerosis is an autoimmune disease in which the body's immune system attacks the...

    https://mschristian.org/index.php/blog/researchers-optimize-aptamer-with-enhanced-myelin-binding-properties-for-ms-treatment
  • How does MS affect the eyes?

    attacks. Researchers are performing more comprehensive research, but in the meantime, some doctors recommend that their MS patients take vitamin D supplements to support their body. Anyone who notices new symptoms or whose symptoms begin to get worse...

    https://mschristian.org/index.php/blog/how-does-ms-affect-the-eyes-1
  • Tysabri (natalizumab) approved for MS

    remitting MS that has not responded to other treatment * reduces relapse rate * IV infusion once every four weeks * 1/3 of patients improve in disability, suppresses 90% of MRI disease * increases risk (1:1000) of viral infection of the brain *...

    https://mschristian.org/index.php/articles/ms-medications/19-tysabri-natalizumab-approved-for-ms
  • Alemtuzumab (CAMPATH)

    The Campath Distribution Program was developed to ensure continued access to Campath® (alemtuzumab) for appropriate patients. Effective September 4, 2012 Campath will no longer be available commercially, but will be provided through the Campath...

    https://mschristian.org/index.php/articles/ms-medications/22-alemtuzumab-campath-not-yet-approved-for-ms

Results 1 - 10 of 10
 
 
 

Follow Us on Twitter

Follow Us On Twitter - Image